Prof. Dr. Mutlu  ARAT

Prof. Dr.
Mutlu ARAT

Hematology

Hospitals 
  • Şişli Florence Nightingale Hospital Abide-i Hurriyet Cad. No: 164 Sisli - Istanbul Show in Map
  • Gayrettepe Florence Nightingale Hospital Cemil Aslan Güder Sok. No: 8 Gayrettepe - İstanbul Show in Map
  • Part-Time, Consultant Works

Prof. Dr. Mutlu Arat graduated from the Medical Faculty of Hacettepe University in 1991. After his specialization in internal diseases, he finished his specialty minor program in hematology. While Prof. Dr. Mutlu Arat was the transplantation coordinator of the Department of Hematology at the Medical Faculty of Ankara University, he performed over 1.400 bone marrow transplantations.

Prof. Dr. Mutlu Arat is the founder of Bone Marrow Transplantation Center of Group Florence Nightingale Hospitals, where he started to work in 1991. He and his team take justified pride of performing over 600 transplantations, over 350 autolog over 250 allogenic transplantations, since the foundation of our center. 

Interests:
  • Bone Marrow Transplantation
  • Leucemia, Lymphoma, Mutliple Myeloma 
  • Late side effects of GVHD

Today
  • 2010 İstanbul Bilim University Faculty of Medicine Dept of Internal Medicine/Hematology Professor
  • 2008 University of Minnesota Dept. of HOT, BMT Unit, Minneapolis, A.B.D. Visiting Prof
  • 2004 - 2009 Ankara University Faculty of Medicine Dept. of Hematology Assoc. Prof
  • 2001 Ankara University Faculty of Medicine Hematologist
  • 2001 - 2004 Ankara University Faculty of Medicine Dept. of Hematology Hematologist
  • 1999 - 2001 Ankara University Faculty of Medicine Dept. of Hematology Fellow
  • 1997 - 1999 Ankara University Faculty of Medicine Dept. of Hematology Internist
  • 1996 Ankara University Faculty of Medicine Internist
  • 1996 - 1997 University of Vienna KMT Unit Observer - Donau Spital
  • 1991 Hacettepe University Medical Faculty MD

  • European Blood and Marrow Transplantation Group (EBMT)
  • LEWP secretary(2006- 2012 )
  • Joint Accreditation Committee ISHAGE Europe (JACIE)
  • Inspector (Clinic/Collection Facility) (31.08.2004- )
  • European Hematology Association (EHA)(# 3873)
  • EHA Education Committee (2009-2013 )
  • American Society of Hematology (ASH, #1001725)
  • American Society of Bone Marrow Transplantation ( ASBMT, #4565)

Publications

Ad Hoc Reviewer

  • Bone Marrow Transplantation
  • Haematologica
  • Therapeutic Apheresis Dialysis
  • Transfusion and Apheresis Science
  • Journal of Clinical Apheresis
  • Journal of National Medical Sciences
  • Turkish Journal of Hematology 
  • Tuberculosis and Thorax 
  • Gülhane Medical Journal 
  • Journal of Clinical Case Reports
  • Annals of Hematology
  • Transplant International

National Congresses and Publications in Journals

1.Koç H, Arslan Ö, Gürman G, Akan H, Özcan M, İlhan O, Aydoğdu İ, Arat M, Beksaç M, Konuk N, Uysal A. The use of high dose chemotherapy plus granulocyte colony stimulating factor for the salvage of refractory ort resistant relapse malignant lymphoma patients without stem cell support. Acta Haematol 1997; 98: 136-139

2.Dilek İ, Demirer T, Üstün C, Arat M, Koç H, Beksaç M, Erdi H, Anadolu R, Özcan M, İhan O, Akan H. Acquired icthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantion in a patient wİth chronic myelogenous leukemia. Bone Marrow Transplant 1998; 21: 1159-1161

3.Beksaç M, Arslan Ö, Koç H, Akan H, İlhan O, Arat M, Özcan M, Gürman G, Konuk N., Uysal A. Randomized unicenter trial for comparison of three regimens in de novo adult acute nonlymphoblastic leukemia. Medical Oncology 1998; 15: 183-190

4.Beksaç M, Arat M, İdilman R. Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced indolent non-Hodgkin’s lymphoma. Cancer 1998; 85: 242 (letter)

5.Arslan Ö, Üstün C, Arat M, Çelebi H, Akan H, Beksaç M, Ilhan O, Gürman G, Özcan M, Konuk N, Uysal A, Koç H. Allogeneic peripheral blood stem cell transplantation in acute nonlymphoblastic leukemia. Hematol Oncol 1998; 16: 115-162

6.Üstün C, Arslan Ö, Beksaç M, Koç H, Gürman G, Özçelik T, Yılmaz B, İlhan O, Akan H, Özcan M, Demirer T, Uysal A, Konuk N, Arat M, Dilek İ, Çelebi H, Çoşkun HŞ. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center, a focus on the incidence of GVHD and relapse. Biol Blood Marrow Transplant 1999;5:28-35

7.İlhan O, Arslan Ö, Arat M, Beksaç M, Akan H, Koç H, Dilek İ, Özcan M, Gürman G, Konuk N, Uysal A. The impact of CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation. Trans Sci 1999;20:69-71

8.Üstün C, Çelebi H, Arat M, Özcan M, Dilek İ, Gürman G, Demirer T, İlhan O, Keskin R, Koç H. Treatment of aregeneratoric anemia following an ABO-Incompatible allogeneic peripheral blood stem cell transplantation. Ther Apher 1999;3:275-77

9.Demirer T, Çelebi H, Arat M, Üstün C, Demirer S, Dilek İ, Özcan M, İlhan O, Akan H, Gürman G, Koç H. Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy following an autologous blood stem cell transplantation: a case report. Bone Marrow Transplant 1999;24:335-338

10.Üstün C, Özcan M, Gürman G, Çakır M, Erekul S, Akyol G, Arat M, Çelebi H, İdilman R, İhan O, Demirer T, Beksaç M, Koç H. Differences in liver pathology and clinical outcome between two patients with hepatitis B virus and graft versus host disease. Pathol Oncol Res 1999;5:229-232

11.Demirer T, llhan O, Mandel N.M., Arat M, Günel N, Çelebi H, Üstün C, Akan H, Demirer S, Aydıntuğ S, Uysal A and Koç H. A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies . Bone Marrow Transplant 2000;25:697-703

12.Arslan Ö, Coşkun H.Ş, Arat M, Çelebi H, Özcan M, Gürman G, Üstün C, Demirer T, Akan H, İlhan O, Konuk N, Beksaç M, Uysal A, Koç H. Allogeneic peripheral blood stem cell transplantation for standard risk leukemias: Four years experience of Ibni Sina Hospital. Bone Marrow Transplant 2000;25:1229-1232

13.Arslan Ö, Akan H, Arat M, Dalva K, Özcan M, Gürman G, İlhan O, Konuk N, Beksaç M, Uysal A, Koç H. Soluble adhesion molecules (sICAM-l, sL-Selectin, sE-Selectin, sCD44) in healthy allogeneic peripheral stem cell donors primed with recombinant granulocyte colony stimulating factor. Cytother 2000; 2: 259-265

14.Ilhan O, Üskent N, Arslan Ö, Arat M, Özkalemkaş F, Öztürk G, Kalayoğlu S.B, Özet A, Tombuloğlu M, Arpacı F, Ovalı E, Anak S. On behalf of Turkish Apheresis Group. National survey of hemapheresis practice in Turkey (1998) Trans Sci 2000; 22: 195-201

15.Akan H, Güven N, Aydoğdu I, Arat M, Beksaç M, Dalva K. Thrombopoietic cytokines in patinents with iron deficiency anemia with or without thrombocytosis. Acta Haematol 2000; 103: 152-156

16.Beksaç M, Arat M, Akan H, Koç H, İlhan O, Özcan M. Circulating CD44 and ICAM-1 levels in low grade non-Hodgkin’s lymphoma and B-CLL patients during interferon alpha- 2a treatment. Cancer 2000; 89: 1474-1481

17.Çelebi H, Akan H, Akçağlayan E, Üstün C, Arat M. Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies. Bone Marrow Transplant 2000; 26: 211-214

19.Özcan M, Üstün C, Akçağlayan E, Akan H, Arslan Ö, İlhan O, Beksaç M, Gürman G, Demirer T, Arat M, Çelebi H, Konuk N, Uysal A, Koç H. Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2000; 27: 499-505

20.Gurman G, Çelebi H, Üstün C, Arat M, İlhan O, Özcan M, Arslan Ö, Uysal A, Akan H, Beksaç M, Konuk N, Koç H. Allogeneic peripheral blood stem cell transplantation for severe aplastic anemia. Ther Apher 2001; 5: 54-57

21.Demirer T, İlhan O, Arat M, Genç İ, Özcan M, Dalva K, Çelebi H, Beksaç M, Akan H, Gürman G, Konuk N, Uysal A, Arslan Ö, Koç H. CD41+ and CD42+ hematopoietic cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation. J Clin Apher 2001; 16: 67-73

22.Gürman G, Dilek İ, Arslan Ö, Arat M, Beksaç M, İlhan O, Özcan M, Akan H, Dalva K, Konuk N, Uysal A, Koç H. The effect of G-CSF on lymphocyte subsets and CD34+ cells in allogeneic stem cell transplantation. Trans Sci 2001; 24: 23-28

23.Arat M, Arslan Ö., Keven K., Nergizoğlu G., Üstün C., Beksaç, M. Hematopoietic cell transplantation-related nephropathy. Am J Kid Dis 2001; 38: 218-219 (letter)

24.Arat M., Ilhan O, Akçağlayan E, Çelebi H, Koç H, Akan H. Treatment of extensive chronic scleradermatous graft-versus-host disease with high dose immunosupressive therapy and CD34+ autologous stem cell rescue. Blood 2001; 98: 892 (letter)

25.Beksaç M, Ma M, Akyerli C, DerDanielian M, Zhang L, Liu J, Arat M, Konuk N, Koç H, Özçelik T, Vescio R, Berenson JR. Frequent demonstration of human herpesvirus 8 (HHV-8) in bone marrow biopsy samples from Turkish patients with multiple myeloma (MM). Leukemia 2001; 15: 1268-1273

26.Gürman G, Arat M., İlhan O., Konuk N., Beksaç M., Çelebi H., Özcan M., Arslan Ö., Üstün C., Akan H., Uysal A., Koç H. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies. Cytother 2001; 3: 253-260
3-7

27.Üstün C, Arat M, Çelebi H, Akan H, İlhan O, Özçelik T, Burgess RE, Koç H. Extramedullary relapse following allogeneic stem cell transplantation in acute promyelocytic leukemia. Haematologica 2001; 86 :E31 (e-letter)

28.Arat M, Ulusoy V, Demirer T, Uysal AV, Özcan M, Dinçer S, İlhan O, Koç H. An unusual presentation of plasma cell dyscrasias: Cardiac tamponade due to myelomatous infiltration. Leuk Lymphom 2002; 43: 145-148

29.Bozkaya H, Yurdaydin C, Törüner M, Arat M, Bozdayi A.M, Erekul S, Çınar K, Koç H, Uzunalimoğlu Ö. Remission of Severe Aplastic Anemia Associated with Hepatitis B Virus Infection After Viral Clearance: Potential Role of Lamivudine. Dig Dis Sci 2002; 47: 1782-1785

30.Demirer T, Dağlı M, İlhan O, Aylı M, Haznedar R, Fen T, Günel N, Genç Y, Arat M, Özcan M, Arslan O, Seyrek E, Dinçer S, Üstün T, Ustael N, Koç H, Müftüoğlu O, Akan H. A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs. 12 liters. Bone Marrow Transplant 2002;29:893-897

31.Demirer T, İlhan O, Aylı M, Arat M, Dağlı M, Özcan M, Haznedar R, Genç Y, Fen T, Ayyıldız E, Dincer S, Arslan Ö, Gürman G, Konuk N, Dalva K, Uysal A, Koç H, Özet G, Akan H. Monitoring of Peripheral Blood CD34+ Cell Counts on the First Day of Apheresis Is Highly Predictive for Efficient CD34+ Cell Yield. Ther Apher 2002;6:384-389

32.Tek I, Arslan Ö, Arat M, Ozcan M, Akdağ B, Ilhan O. Effects of replacement fluids on coagulation system used for therapeutic plasma exchange. Trans Apher Sci 2003;28:283–7

33.Unal A.E, Bayar S, Arat M, Ilhan O. Malpositioning of Hickman catheters, left versus right sided attempts. Trans Apher Sci 2003;28:9–12

34.Demirer T, Uysal V.A, Ayli M, Genc Y, Ilhan O, Koc H, Dagli M, Arat M, Gunel N, Fen T, Dincer S, Ustael N, Yildiz M, Ustun T, Seyrek E, Ozet G, Muftuoglu O, Akan H. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation. Bone Marrow Transplant 2003;31:755-61

35.Sanli H, Anadolu R, Arat M, Ekmekci P, Birol A, Erdem C, Koc H. Dermatomal lichenoid graft-versus-host disease within Herpes Zoster scars. Int J Dermatol 2003; 42, 562

36.Sanli H, Ekmekci P, Kusak F, Arat M, Beksaç M. Hyperkeratosis of the nipple associated with chronic graft versus host disease after allogeneic hematopoetic cell transplantation. Acta Dermat-Venereol 2003; 83: 1-2 (letter)

37.Sanli H, Kusak F, Arat M, Ekmekci P, Ilhan O. Simultaneous Onset of Chronic Graft Versus Host Disease and Alopecia Areata Following Allogeneic Haematopoietic Cell Transplantation. Acta Dermato-Venereologica 2003; 84: 86 – 87 (letter)

38.Arat M, Arslan Ö, Gürman G, Dalva K, Özcan M, Uğur A, İlhan O. The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy. Trans Apher Sci 2004; 30: 9-15

39.Topçuoglu P, Arat M, Dalva K, Ozcan M. Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors. Bone Marrow Transplant 2004; 33: 171-6

40.Sanli H, Ekmekci P, Kusak F, Arat M, Gürman G. Clinical manifestations of cutaneous graft-versus-host disease after allogeneic hematopoietic cell transplantation: Long-term follow-up results in a single Turkish Centre. Acta Derm Venereol 2004; 84: 296-301.

41.Idilman R, Arat M, Soydan E, Törüner M, Soykan İ, Beksaç M, Akbulut H, Bozdayı M, Karayalçın S, Van Thiel H, Akan H. Lamivudine prophylaxis for prevention of chemotheraphy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies. J Viral Hepat. 2004; 11: 141–147

42.Sanli H, Arat M, Oskay T, Gürman G. The evaluation of nail involvement in patients with chronic cutaneous graft-versus-host disease: From Turkey, in a single center. Int J Dermatol 2004; 43: 176

43.Arslan Ö, Toprak SK, Arat M, Kayalak Y. Hemoglobin content based transfusion policy succesfully reduces the number of RBC units transfused. Transfusion 2004; 44: 485-488

44.Arslan Ö, Arat M, Tek İ, Ayyıldız E, Ilhan O. Therapeutic plasma exchange in a single center: Ibni Sina experience. Trans Apher Sci 2004; 30: 181-184

45.Ilhan O, Arat M, Arslan Ö, Ayyildiz E, Sanli H, Beksac M, Özcan M, Gürman G, Akan H. Extracorporeal photoimmunotherapy for treatment of steroid refractory progressive chronic graft-versus-host disease: Ibni Sina experience. Trans Apher Sci 2004; 30: 185-187

46.Arat M, Arslan Ö, Ayyildiz E, Topcuoglu P, Dalva K, Ilhan O. Peripheral blood stem cell apheresis for allogeneic transplants: Ibni Sina experience. Trans Apher Sci 2004; 30: 189-191

47.Kuzu I, Beksac M, Arat M, Celebi H, Elhan AH, Erekul S. Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): therapy induced changes and effects on survival. Leukemia Lymphoma 2004; 45: 1185-1190

48.Tek I, Arslan O, Arat M, Ayyildiz E, Tol M, Oral M, Ilhan O. Effects of replacement fluids used for therapeutic plasma exchange on plasma viscosity and plasma oncotic pressure. Transfus Apheresis Sci. 2004; 31: 89-93.

49.Demirer T, Ayli M, Fen T, Ozcan M, Arat M, Buyukberber S, Arslan O, Gurman. G, Akan H, Ilhan O. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma – a retrospective evaluation. Bone Marrow Transplant. 2004; 34: 781-6.

50.Arslan O, Tek I, Arat M, Ciftci I, Ilhan O. Effects of replacement fluids on plasma viscosity used for therapeutic plasma exchange. Ther Apher Dial. 2004; 8: 144-7.

51.Yıldırım I, Özer Y, Kurt Yüksel M, Arat M, Arslan Ö. Erythrocyte antigen and reticulocyte engraftment after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2004; 34: 351-355

52.Arat M, Idilman R, Soydan EA, Soykan I, Erden E., Karayalçın S, Akan H. Ursodeoxycholic acid treatment in isolated chronic graft-vs.-host disease of the liver. Clinical Transplantation 2005; 19: 798-803

53.Idilman R, Erden E, Arat M, Soydan E, Erkan O, Kuzu I, Sahin Y, Coban S, Bozdayi M, Giraud A, Akan H, Karayalcin S, Ozden A. Trefoil factor expression in biliary epithelium of graft-versus-host disease of the liver after allogeneic hematopoietic cell transplantation. Transplantation. 2005; 80: 1099-1104

54.Idilman R, Kuzu I, Erden E, Arat M, Soydan E, Soykan I, Akyol G, Karayalcin S, Akan H, Beksac M. Evaluation of the effect of transplant-related factors and tissue injury on donor-derived hepatocyte and gastrointestinal epithelial cell repopulation following hematopoietic cell transplantation. Bone Marrow Transplant. 2006; 37: 199-206

55.Bakanay SM, Dalva K, Arat M, Arslan O, Ayyildiz E, Beksac M, Ilhan O. Does continuous flow apheresis influence viability in allogeneic hematopoietic stem cell harvest? Transfus Apher Sci. 2006; 34: 171-8.

56.Durdu S, Akar AR, Arat M, Sancak T, Eren NT, Ozyurda U. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans. J Vasc Surg. 2006; 44: 732-9.

57.Parlak M, Sancak T, Arat M, Bilgic S, Sanlidilek U. Tunneled catheters placed in bone marrow transplant patients: radiological and clinical follow-up results. Diagn Interv Radiol. 2006; 12: 190-4.

58.Ayyildiz E, Arslan O, Topcuoglu P, Arat M, Dalva K, Soydan EA, Tol M, Ilhan O. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD). Transfus Apher Sci. 2007; 36: 79-85.

59.Yucesan C, Arslan O, Arat M, Yucemen N, Ayyildiz E, Ilhan O, Mutluer N. Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: Review of 50 cases. Transfus Apher Sci. 2007; 36: 103-107.

60.Buyukkagnici DI, Ilhan O, Kavas GO, Arslan O, Arat M, Dalva K, Ayyildiz E. Effects of plasma nitric oxide levels on platelet activation in single donor apheresis and random donor concentrates. Transfus Apher Sci. 2007; 36: 73-78.

61.Arslan O, Arat M. Apheresis information management system (AMIS). Transfus Apher Sci. 2007; 36:281-3.

62.Soydan E, Ayyildiz E, Dalva K, Topcuoglu P, Tol M, Arslan O, Ilhan O, Arat M. Impact of harvest product volume in erythrocyte depletion of allogeneic or autologous bone marrow using COBE spectra. Transfus Apher Sci. 2007; 36 : 269-273.

63.Topcuoglu P, Akcaglayan Soydan E, Ekiz F, Ayyildiz E, Dalva K, Ozcan M, Arslan O, Arat M, Ilhan O. How to calculate the quantity of CD34+ cells infused? A single center cohort study based on actual, ideal or adjusted ideal body weight. Transfus Apher Sci. 2007; 36: 275-80.

64.Arat M. Selected papers from the 15th Congress of the Interdisciplinary European Society for Hemapheresis and Hemotherapy. Transfus Apher Sci. 2007; 36: 259-60.

65.Sanlı H, Akay BN, Arat M, Koçyigit P, Akan H, Beksac M, Ilhan O. Vitiligo after Hematopoietic Cell Transplantation: Six Cases and Review of the Literature. Dermatology. 2008; 216: 349-354

66.Bektas M, Idilman R, Soykan I, Soydan E, Arat M, Cinar K, Coban S, Tuzun A, Bozkaya H, Ormeci N, Ozden A. Adjuvant Therapeutic Plasma Exchange in Liver Failure: Assessments of Clinical and Laboratory Paramters. J Clin Gastroenterol. 2008; 42: 517-21.

67.Soydan E, Topcuoglu P, Dalva K, Arat M. The impact of methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism on transplant-related variables after allogeneic hematopoietic cell transplantation in patients receiving MTX as GVHD prophylaxis. Bone Marrow Transplant. 2008; 42: 429-30.
Tichelli A, Passweg J, Wójcik D, Rovó A, Harousseau JL, Masszi T, Zander A, Békássy A, Crawley C, Arat M, Sica S, Lutz P, Socié G; on behalf of the EBMT Late Effects Working Party. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the EBMT. Haematologica. 2008; 93: 1203-10.

68.Yazman D, Konuk N, Ozcan M, Arat M, Soydan E, Arslan O, Ilhan O. A case report of the Modified Malmö Protocol: an alternative therapeutic approach to refractory chronic idiopathic thrombocytopenic purpura. Ther Apher Dial. 2008; 12: 255-8.

69.Arat M, Arpaci F, Ertem M, GürmanG, for Turkish Transplant Registry. Turkish Transplant Registry: a comparative analysis of national activity with the EBMT European Activity Survey. Bone Marrow Transplant. 2008; 42: S142–S145

70.Ozden A, Süleyman Z, Seven G, Arat M, Akın A, Sener O, Kuzu I, Keven K, Ensari A, Erden A, Tan E. POEMS syndrome: A case report. Turk J Gastroenterol. 2008; 19: 276-280.

71.Akar AR, Durdu S, Arat M, Kilickap M, Kucuk NO, Arslan O, Kuzu I, Ozyurda U. Five-year follow-up after transepicardial implantation of autologous bone marrow mononuclear cells to ungraftable coronary territories for patients with ischaemic cardiomyopathy. Eur J Cardiothorac Surg. 2009; 36: 633-43.

72.Ozcelik T, Topcuoglu P, Beksac M, Ozcan M, Arat M, Bıyıklı Z, Bakanay SM, Ilhan O, Gurman G, Arslan O, Demirer T. Mobilization of PBSCs with chemotherapy and recombinant human G-CSF: a randomized evaluation of early vs late administration of recombinant human G-CSF. Bone Marrow Transplant. 2009; 44: 779-83.

73.Arat M, Özsan HG, Yenerel MN, Cetin M, Özcan M. 2nd International Congress on Leukemia, Lymphoma and Myeloma. Expert Review of Hematology 2009; 5: 509-512.

74.Tichelli A, Rovó A, Passweg J, Schwarze CP, Van Lint MT, Arat M, Socié G. Late complications after hematopoietic stem cell transplantation. Expert Review of Hematology 2009; 2: 583-601.

75.Kurt RA, Yalçindag N, Atilla H, Arat M. Topical cyclosporine-A in dry eye associated with chronic graft versus host disease. Ann Ophthalmol (Skokie). 2009 Fall-Winter;41(3-4):166-9.

76.Akay BN, Sanli H, Topcuoglu P, Arat M, Akyol A. Nailfold capillary abnormalities are prevalent in sclerodermoid graft-versus-host disease and readily detected with dermatoscopy. Br J Dermatol. 2010 Mar 5. PubMed PMID: 20222922.

77.Gunay-Aygun M, Zivony-Elboum Y, Gumruk F, Geiger D, Cetin M, Khayat M, Kleta R, Kfir N, Anikster Y, Chezar J, Arcos-Burgos M, Shalata A, Stanescu H, Manaster J, Arat M, Edwards H, Freiberg AS, Hart PS, Riney LC, Patzel K, Tanpaiboon P, Markello T, Huizing M, Maric I, Horne M, Kehrel BE, Jurk K, Hansen NF, Cherukuri PF, Jones M, Cruz P, Mullikin JC, Nurden A, White JG, Gahl WA, Falik-Zaccai T. Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p. Blood. 2010 Dec 2;116(23):4990-5001. PMID: 20709904

78.Solh M, Arat M, Cao Q, Majhail NS, Weisdorf D. Late-onset noninfectious pulmonary complications in adult allogeneic hematopoietic cell transplant recipients. Transplantation. 2011 Apr 15;91(7):798-803. PMID: 21403586

79.Idilman R, Bozkus Y, Seval G, Mizrak D, Cinar K, Ustun Y, Bektas M, Arat M, Akbulut H, Doganay B, Ozden A. Lymphoproliferative disorders in individuals with chronic hepatitis B and C in the Turkish population. J Med Virol. 2011 Jun;83(6):974-80. PMID: 21503909.

80.Gunay-Aygun M, Falik-Zaccai TC, Vilboux T, Zivony-Elboum Y, Gumruk F, Cetin M, Khayat M, Boerkoel CF, Kfir N, Huang Y, Maynard D, Dorward H, Berger K, Kleta R, Anikster Y, Arat M, Freiberg AS, Kehrel BE, Jurk K, Cruz P, Mullikin JC, White JG, Huizing M, Gahl WA. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules. Nat Genet. 2011 Jul 17;43(8):732-4. PMID: 21765412

81.Idilman R, Arat M. Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation. Expert Rev Anti Infect Ther. 2011 Aug;9(8):641-52. doi: 10.1586/eri.11.79. Review. PubMed PMID: 21819330.

82.Topcuoglu P, Arat M, Ozcan M, Arslan O, Ilhan O, Beksac M, Gurman G. Case-matched comparison with standard versus reduced intensity conditioning
regimen in chronic myeloid leukemia patients. Ann Hematol. 2012 Apr;91(4):577-86. PMID: 21971669.

83.Gürgan CA, Özcan M, Karakuş Ö, Zincircioğlu G, Arat M, Soydan E, Topcuoglu P, Gürman G, Bostancı HS. Periodontal status and post-transplantation complications following intensive periodontal treatment in patients underwent allogenic hematopoietic stem cell transplantation conditioned with myeloablative regimen.  Int J Dent Hyg. 2013 May;11(2):84-90. PMID: 22487659.

84.Rovó A, Aljurf M, Chiodi S, Spinelli S, Salooja N, Sucak G, Hunter A, Kim TS, Socié G, van Lint MT, Passweg JR, Arat M, Badoglio M, Tichelli A; Late Effects Working Party of the EBMT. Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow
Transplantation. Haematologica. 2013 Mar;98(3):339-45. doi: 10.3324/haematol.2012.071944.
Rovó A, Aljurf M, Chiodi S, Spinelli S, Salooja N, Sucak G, Hunter A, Kim TS, Socié G, van Lint MT, Passweg JR, Arat M, Badoglio M, Tichelli A. Paternity wishes in long-term survivors after allogeneic hematopoietic SCT. A study of the late effects working party of the EBMT. Bone Marrow Transplant. 2013 Jun;48(6):878-9. PMID: 23292242.

85.Tichelli A, Labopin M, Rovó A, Badoglio M,Arat M, van Lint MT, Lawitschka A, Schwarze CP, Passweg J, Socié G. Increase of suicide and accidental death after hematopoietic stem cell transplantation: a cohort study on behalf of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Cancer. 2013 Jun 1;119(11):2012-21. doi: 10.1002/cncr.27987. Epub 2013 Mar 19. PubMed PMID: 23512286.

86.Bozdag SC, Topcuoglu P, Kuzu I, Arat M. Acute lymphoblastic leukemia during enzyme replacement therapy in type 1 Gaucher's disease. Clin Adv Hematol Oncol. 2013 Apr;11(4):251-2. PubMed PMID: 23604243.

Do you want to keep informed about us?
florence nightingale hastanesi

Copyright 2016 Group Florence Nightingale Hospitals. All rights reserved.

The information on this website is not intended to replace any medical advice given by physicians with access to your detailed medical history.